Search

everythinglearnresearchcommunity

for

Search:↓

Genetic factors and diet significantly increase the risk of male pattern baldness.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Certain genetic markers and low vitamin D3 levels are linked to male pattern baldness.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

There's no significant link between blood fat levels and male pattern baldness.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

Use "female pattern hair loss" term, finasteride may help, more research needed.

Severe hair loss links to metabolic issues in older men with psoriasis.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Severe and early hair loss may indicate a higher risk of heart disease.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Male pattern baldness does not cause an increased risk of prostate cancer.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Immune activities and specific genes are important in male pattern baldness.

Supplemented Erzhi Wan may help regrow hair in male pattern baldness by affecting certain cell signaling pathways.

Topical cetirizine may help increase hair length in male pattern baldness and could be an alternative to minoxidil with fewer side effects.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Eating vegetarian, having allergies, and family history might be linked to getting gray hair early.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Men with severe hair loss may have a higher risk of heart disease.

Early onset hair loss linked to genetics and androgen levels.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.